11β-hydroxysteroid dehydrogenases: Changing glucocorticoid action

Current Opinion in Pharmacology

Volumn 4, Issue 6, 2004, Pages 597-602

  Seckl, Jonathan R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; CARBENOXOLONE; CORTICOSTERONE; CORTISONE; DEHYDROCORTICOSTERONE; GLUCOCORTICOID; HYDROCORTISONE; ISOENZYME; MESSENGER RNA; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; BRAIN; CATALYSIS; CENTRAL NERVOUS SYSTEM DISEASE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME DEFICIENCY; HORMONE ACTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; LIVER; METABOLIC REGULATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ANIMAL; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; GENETICS; METABOLISM;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; CORTISONE; DOUBLE-BLIND METHOD; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE;

EID: 13944255183     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.09.001     Document Type: Review

References (61)

1. D. Amelung H.J. Huebener L. Roka G. Meyerheim Conversion of cortisone to compound F J Clin Endocrinol Metab 13 1953 1125-1126
2. C.R.W. Edwards P.M. Stewart D. Burt L. Brett M.A. McIntyre W.S. Sutanto E.R. de Kloet C. Monder Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor Lancet ii 1988 986-989
3. J.W. Funder P.T. Pearce R. Smith A.I. Smith Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated Science 242 1988 583-585
4. V. Lakshmi C. Monder Purification and characterisation of the corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex Endocrinology 123 1988 2390-2398
5. S.C. Low S.N. Assaad V. Rajan K.E. Chapman C.R.W. Edwards J.R. Seckl Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo: Further evidence for the existence of a second dehydrogenase in rat kidney J Endocrinol 139 1993 27-35
6. A.L. Albiston V.R. Obeyesekere R.E. Smith Z.S. Krozowski Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme Mol Cell Endocrinol 105 1994 R11-R17
7. R.W. Brown Y. Kotolevtsev C. Leckie R.S. Lindsay V. Lyons P. Murad J.J. Mullins K.E. Chapman C.R.W. Edwards J.R. Seckl Isolation and cloning of human placental 11β-hydroxysteroid dehydrogenase-2 cDNA Biochem J 313 1996 1007-1017
8. T. Mune F.M. Rogerson H. Nikkilä A.K. Agarwal P.C. White Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase Nat Genet 10 1995 394-399
9. Y. Kotelevtsev R.W. Brown S. Fleming C.J. Kenyon C.R.W. Edwards J.R. Seckl J.J. Mullins Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2 J Clin Invest 103 1999 683-689
10. J. Seckl K. Chapman N. Morton B. Walker Glucocorticoids and 11β-hydroxysteroid dehydrogenase in adipose tissue Rec Prog Horm Res 2004 359-393
11. D.E.W. Livingstone G. Jones K. Smith P.M. Jamieson R. Andrew C.J. Kenyon B.R. Walker Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats Endocrinology 141 2000 560-563
12. H. Masuzaki J. Paterson H. Shinyama N.M. Morton J.J. Mullins J.R. Seckl J.S. Flier A transgenic model of visceral obesity and the Metabolic Syndrome Science 294 2001 2166-2170
13. E. Rask T. Olsson S. Soderberg R. Andrew D.E.W. Livingstone O. Johnson B.R. Walker Tissue-specific dysregulation of cortisol metabolism in human obesity J Clin Endocrinol Metab 86 2001 1418-1421
14. E. Rask B.R. Walker S. Soderberg D.E.W. Livingstone M. Eliasson O. Johnson R. Andrew T. Olsson Tissue-specific changes in peripheral cortisol metabolism in obese women: Increased adipose 11 β-hydroxysteroid dehydrogenase type 1 activity J Clin Endocrinol Metab 87 2002 3330-3336
15. R.S. Lindsay D.J. Wake S. Nair J. Bunt D.E.W. Livingstone P.A. Permana P.A. Tataranni B.R. Walker Subcutaneous adipose 11 β-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians J Clin Endocrinol Metab 88 2003 2738-2744
16. D.J. Wake E. Rask D.E.W. Livingstone S. Soderberg T. Olsson B.R. Walker Local and systemic impact of transcriptional up-regulation of 11 β-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity J Clin Endocrinol Metab 88 2003 3983-3988
17. O. Paulmyer-Lacroix S. Boullu C. Oliver M.C. Alessi M. Grino Expression of the mRNA coding for 11 β-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: An in situ hybridization study J Clin Endocrinol Metab 87 2002 2701-2705
18. J. Westerbacka H. Yki-Järvinen S. Vehkavaara A. Häkkinen R. Andrew D. Wake J. Seckl B. Walker Body fat distribution and cortisol metabolism in healthy men: Enhanced 5-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver J Clin Endocrinol Metab 88 2003 4924-4931
19. J.W. Tomlinson B. Sinha I. Bujalska M. Hewison P.M. Stewart Expression of 11 β-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity J Clin Endocrinol Metab 87 2002 5630-5635
20. P.M. Stewart A. Boulton S. Kumar P.M.S. Clark C.H.L. Shackleton Cortisol metabolism in human obesity: Impaired cortisone → cortisol conversion in subjects with central adiposity J Clin Endocrinol Metab 84 1999 1022-1027
21. I. Bujalska S. Kumar P.M. Stewart Central obesity: 'Cushing's disease of the omentum' Lancet 349 1997 1210-1213
22. B. Walker J. Seckl Cortisol Metabolism In International Textbook of Obesity 2001 edited by P. Björntorp John Wiley and Sons 241-268
23. H. Masuzaki H. Yamamoto C.J. Kenyon J.K. Elmquist N.M. Morton J.M. Paterson H. Shinyama M.G.F. Sharp S. Fleming J.J. Mullins et al. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice J Clin Invest 112 2003 83-90
24. C. Weyer T. Funahashi S. Tanaka K. Hotta Y. Matsuzawa R.E. Pratley P.A. Tataranni Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 2001 1930-1935
25. G. Hotamisligil N. Shargill B. Spiegelman Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance Science 259 1993 87-91
26. C. Steppan S. Bailey S. Bhat E. Brown R. Banerjee C. Wright H. Patel R. Ahima M. Lazar The hormone resistin links obesity to diabetes Nature 409 2001 307-312
27. J. Paterson N. Morton C. Fievet C. Kenyon M. Holmes B. Staels J. Seckl J. Mullins Metabolic syndrome without obesity: Hepatic over-expression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice Proc Natl Acad Sci USA 101 2004 7088-7093
28. A. Johansson R. Andrew H. Forsberg K. Cederquist B.R. Walker T. Olsson Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy J Clin Endocrinol Metab 86 2001 4276-4283
29. Y. Kotelevtsev M.C. Holmes A. Burchell P.M. Houston D. Schmoll P.M. Jamieson R. Best R. Brown C.R.W. Edwards J.R. Seckl et al. 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity or stress Proc Natl Acad Sci USA 94 1997 14924-14929
30. N.M. Morton M.C. Holmes C. Fievet B. Staels J.J. Mullins J.R. Seckl Improved lipid and lipoprotein profile, hepatic insulin sensitivity and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice J Biol Chem 276 2001 41293-41300
31. N. Morton J. Paterson H. Masuzaki M.C. Holmes B. Staels C. Fievet B. Walker J. Flier J. Mullins J. Seckl Novel adipose tissue-mediated resistance to diet induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1 deficient mice Diabetes 53 2004 931-938
32. A. Hermanowski-Vosatka D. Gerhold S.S. Mundt V.A. Loving M.Q. Lu Y.L. Chen A. Elbrecht M. Wu T. Doebber L. Kelly et al. PPARα agonists reduce 11 β-hydroxysteroid dehydrogenase type 1 in the liver Biochem Biophys Res Commun 279 2000 330-336
33. J. Berger M. Tanen A. Elbrecht A. Hermanowski-Vosatka D.E. Moller S.D. Wright R. Thieringer Peroxisoime proliferator-activated receptor-g ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity J Biol Chem 276 2001 12629-12635
34. N. Morton L. Ramage J. Seckl Down-regulation of adipose 11β-hydroxysteroid dehydrogenase type 1 by high fat feeding in mice: A potential adaptive mechanism counteracting metabolic disease Endocrinology 145 2004 2707-2712
35. G. Phillipov M. Palermo C.H.L. Shackleton Apparent cortisone reductase deficiency: A unique form of hypercortisolism J Clin Endocrinol Metab 81 1996 3855-3860
36. N. Draper E.A. Walker I.J. Bujalska J.W. Tomlinson S.M. Chalder W. Arlt G.G. Lavery O. Bedendo D.W. Ray I. Laing et al. Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency Nat Genet 34 2003 434-439
37. S. Nair Y. Lee R. Lindsay B. Walker P. Tataranni C. Bogardus L. Baier P. Permana The 11β hydroxysteroid dehydrogenase type 1 gene: Genetic polymorphisms are associated with type 2 diabetes in Pima indians independently of obesity and expression in adipocyte and muscle Diabetologia 47 2004 1088-1095
38. T. Barf J. Vallgarda R. Emond C. Haggstrom G. Kurz A. Nygren V. Larwood E. Mosialou K. Axelsson R. Olsson et al. Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11 β-hydroxysteroid dehydrogenase type 1 J Med Chem 45 2002 3813-3815
39. P. Alberts L. Engblom N. Edling M. Forsgren G. Klingstrom C. Larsson Y. Ronquist-Nii B. Ohman L. Abrahmsen Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice Diabetologia 45 2002 1528-1532
40. P. Alberts C. Nilsson G. Selen L. Engblom N. Edling S. Norling M. Forsgren G. Klingstrom C. Larsson M. Forsgren Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycaemic mice strain Endocrinology 144 2003 4755-4762
41. H. Speirs J. Seckl R. Brown Ontogeny of glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase type 1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development J Endocrinol 181 2004 105-116
42. S. Hundertmark A. Dill A. Ebert B. Zimmermann Y.V. Kotelevtsev J.J. Mullins J.R. Seckl Foetal lung maturation in 11β-hydroxysteroid dehydrogenase type 1 knockout mice Horm Metab Res 34 2002 545-549
43. R. Thieringer C. Le Grand L. Carbin T.-Q. Cai B. Wong S.D. Wright A. Hermanowski-Vosatka Hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages J Immunol 167 2001 30-35
44. E.R. de Kloet Brain corticosteroid receptor balance and homeostatic control Front Neuroendocrinol 12 1991 95-164
45. B.S. McEwen Stress and hippocampal plasticity Annu Rev Neurosci 22 1999 105-122
46. B.L. Roland K.X.Z. Li J.W. Funder Hybridization histochemical localization of 11β-hydroxysteroid dehydrogenase type 2 in rat brain Endocrinology 136 1995 4697-4700
47. A.C. Robson C. Leckie J.R. Seckl M.C. Holmes Expression of 11β-hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain Brain Res Mol Brain Res 61 1998 1-10
48. M.-P. Moisan J.R. Seckl C.R.W. Edwards 11β-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus and cortex Endocrinology 127 1990 1450-1455
49. V. Lakshmi R.R. Sakai B.S. McEwen C. Monder Regional distribution of 11β-hydroxysteroid dehydrogenase in rat brain Endocrinology 128 1991 1741-1748
50. V. Rajan C.R.W. Edwards J.R. Seckl 11β-hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity J Neurosci 16 1996 65-70
51. R.R. Sakai V. Lakshmi C. Monder B.S. McEwen Immunocytochemical localisation of 11β-hydroxysteroid dehydrogenase in hippocampus and other brain regions of the rat J Neuroendocrinol 4 1992 101-106
52. H.J. Harris Y. Kotelevtsev J.J. Mullins J.R. Seckl M.C. Holmes 11β-hydroxysteroid dehydrogenase type 1 null mice have altered hypothalamic-pituitary-adrenal axis activity: A novel control of glucocorticoid feedback Endocrinology 142 2001 114-120
53. P.W. Landfield J. Waymire G. Lynch Hippocampal aging and adrenocorticoids: A quantitative correlation Science 202 1978 1098-1102
54. M.J. Meaney D.H. Aitken C. van Berkel S. Bhatnagar R.M. Sapolsky Effect of neonatal handling on age-related impairments associated with the hippocampus Science 239 1988 766-768
55. O.A. Ajilore R.M. Sapolsky In vivo characterization of 11β-hydroxysteroid dehydrogenase in rat hippocampus using glucocorticoid neuroendangerment as an endpoint Neuroendocrinology 69 1999 138-144
56. J.L.W. Yau J. Noble C.J. Kenyon C. Hibberd Y. Kotelevtsev J.J. Mullins J.R. Seckl Lack of tissue glucocorticoid reactivation in 11β-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments Proc Natl Acad Sci USA 98 2001 4716-4721
57. T. Sandeep J. Yau A. MacLullich J. Noble I. Deary B. Walker J. Seckl Effects of 11β-hydroxysteroid dehydrogenase inhibition on cognitive function in healthy elderly men and patients with type 2 diabetes Proc Natl Acad Sci USA 101 2004 6734-6739
58. M.W.J. Strachan I.J. Deary F.M.E. Ewing B.M. Frier Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies Diabetes Care 20 1997 438-445
59. B.R. Walker A.A. Connacher R.M. Lindsay D.J. Webb C.R.W. Edwards Carbenoxolone increases hepatic insulin sensitivity in man: A novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation J Clin Endocrinol Metab 80 1995 3155-3159
60. R.C. Andrews O. Rooyackers B.R. Walker Effects of the 11 β-hydroxysteroid dehydrogrenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes J Clin Endocrinol Metab 88 2003 285-291
61. D.J.F. de Quervain R. Poirier M.A. Wollmer L.M.E. Grimaldi M. Tsolaki J.R. Streffer C. Hock R.M. Nitsch M.H. Mohajeri A. Papassotiropoulos Glucocorticoid-related genetic susceptibility for Alzheimer's disease Hum Mol Genet 13 2004 47-52